State Clinical Trials Law
Conn. Gen. Stat. Ann. §§ 38a-483c, 38a-504a – 38a-504g, 38a-513b, 38a-542a – 38a-542g
Who must cover the costs? Individual and group health insurance plans
What must be covered? Routine patient care costs associated with cancer clinical trials. the insurer may require documentation of the likelihood of therapeutic benefit, informed consent, protocol information and test results, and/or a summary of the costs involved.
Requirements for Coverage: Insurers must pay for routine patient costs only for Phase III clinical trials, that involve “therapeutic intervention,” and are conducted at multiple institutions.
Qualifying Trials: The clinical trial protocol must be reviewed & approved by (1) NIH, (2) NCI cooperative group, (3) U.S. F.D.A. in the form of an investigational new drug application, (4) U.S. Dept. of Defense, or (5) U.S. Dept. of Veterans Affairs.
(Last update 8/2022)